Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 1
Journal homepage
115
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study

Akira OnishiDepartment of Evidence Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan;Department of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Daisuke SugiyamaDepartment of Evidence Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Go TsujiDepartment of Rheumatic Diseases, Shinko Hospital, 1-4-47 Wakihama-cho, Chuo-ku, Kobe 651-0072, Japan
,
Takashi NakazawaDepartment of Rheumatology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan
,
Yoshinori KogataDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Kosaku TsudaDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Ikuko NakaDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Keisuke NishimuraDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Kenta MisakiDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Chiyo KurimotoDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Hiroki HayashiDepartment of Nephrology, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192,, Japan
,
Goichi KageyamaDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Jun SaegusaDepartment of Evidence Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Takeshi SugimotoDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Seiji KawanoDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
,
Shunichi KumagaiDepartment of Evidence Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan;Department of Rheumatic Diseases, Shinko Hospital, 1-4-47 Wakihama-cho, Chuo-ku, Kobe 651-0072, Japan
&
Akio MorinobuDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanCorrespondence[email protected]
 show all
Pages 89-96 | Received 22 Dec 2011, Accepted 08 Mar 2012, Published online: 02 Jan 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Denis Wakefield. (2014) Does Cyclophosphamide Still Have a Role in the Treatment of Severe Inflammatory Eye Disease?. Ocular Immunology and Inflammation 22:4, pages 306-310.
Read now

Articles from other publishers (8)

Naoaki Ohkubo, Shigeru Iwata, Kazuhisa Nakano, Ippei Miyagawa, Kentaro Hanami, Shunsuke Fukuyo, Yusuke Miyazaki, Akio Kawabe, Shingo Nakayamada & Yoshiya Tanaka. (2022) Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis. Modern Rheumatology 32:6, pages 1077-1085.
Crossref
Kang Li, Yanqiu Yu, Yuan Gao, Fei Zhao, Zheng Liang & Junjie Gao. (2022) Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis. Frontiers in Immunology 13.
Crossref
Yoshiya Tanaka, Sean O'Neill, Mengtao Li, I‐Ching Tsai & Ya‐Wen Yang. (2022) Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region. Arthritis Care & Research 74:2, pages 187-198.
Crossref
Yoshiyuki Abe, Kurisu Tada, Ken Yamaji & Naoto Tamura. (2021) Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study. BioMed Research International 2021, pages 1-7.
Crossref
Phelisa Sogayise, Udeme Ekrikpo, Ayanda Gcelu, Bianca Davidson, Nicola Wearne, Ugochi Okpechi-Samuel, Theophilus Ifeanyichukwu Umeizudike, Innocent Ijezie Chukwuonye & Ikechi Okpechi. (2020) Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa. International Journal of Nephrology 2020, pages 1-7.
Crossref
Mai Kawazoe, Kaichi Kaneko, Zento Yamada, Shotaro Masuoka, Satoshi Mizutani, Soichi Yamada, Kotaro Shikano, Hiroshi Sato, Makoto Kaburaki, Sei Muraoka, Shinichi Kawai & Toshihiro Nanki. (2019) Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus. Clinical Rheumatology 38:6, pages 1571-1578.
Crossref
Chayawee Muangchan & Janet E. Pope. (2016) Reply. Arthritis Care & Research 68:9, pages 1385-1386.
Crossref
Lucy Croyle & Eric F. Morand. (2015) Optimizing the use of existing therapies in lupus. International Journal of Rheumatic Diseases 18:2, pages 129-137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.